Malignant hematopathology (detailed) 12/20 Flashcards
Precursor B and T cell neoplasms
ALL: most common is B cell, more common younger than 15, peak at 4 y/o and M>F
T cell types are associated with a mediastinal mass, teenagers
Pre-B=TdT+,CD19+,CD10+
Pre-T=CD1,2,5,7+, CD3,4,8-
Peripheral T=CD3,4,8+
ALL
majority have numerical or structural changes
abrupt or stormy onset
bone pain or tenderness
CNS manifestation
generalized lymphadenopathy, hepatosplenomegaly
Worse prognosis for ALL
less than 2 y/o or older age
blasts>100,000
unfavorable genetics
Ph chromosome (9,22)
Peripheral B cell neoplasms
CLL or SLL
CD19,20+ but also CD5,23+(even though these are T-cell markers)
mostly older pts>50
often asymptomatic
prolymphocytic transformation and Richter’s syndrome
Follicular lymphoma
most common NHL in US
middle age, M=F
CD19,20,10,SIg,BCl6+
t(14,18)–>18=BCl2
indolent course and incurable
can transform into DLBCL
DLBCL
heterogenous group of tumors
20% of NHL,5% of childhood lymphoma,60-70% of aggressive lymphomas
old male pts
CD19,20+, variable CD10,BCL6 and SIg
c-myc mutations, some show t(14,18)
immunodeficiency-associated and body cavity large cell lymphomas
Can present as enlarging mass with poor prognosis
DLBCL in liver
is characterized by fish-flesh appearance
Burkitt lymphoma
t(8,14), c-myc translocation
CD19,20,10,BCL6+
endemic seen in mandible and abdominal viscera, sporadic seen as abdominal mass of ileocecum and peritoneum
responds to therapy and children have better prognosis
Starry sky appearance
Mantle Cell lymphoma
t(11,14), 11=cyclin D1
M>F, 5th-6th decades
CD19,20,5+ but CD23-
painless lymphadenopathy or splenomegaly and can involve GI
poor prognosis
transformation uncommon
Marginal zone lymphoma
MALToma
often in tissues with autoimmune disease=H pylori gastritis, hashimoto thyroiditis
remains localized for prolonged periods and may regress with eradication of inciting agent
anaplastic large cell lymphoma (peripheral T cell lymphoma)
rearrangement of ALK gene on chromosome 2P23
children and young adults
frequently involve soft tissues
good prognosis and curable
older adults lack ALK and have poor prognosis
Slide can be stained with ALK stain
peripheral T and NK cell lymphoma
lack TdT but CD2,5,3,4,8+
generalized lymphadenopathy, eosinophilia,fever, pruritis and weight loss
aggressive and has poor prognosis
See cerebriform morphology of cells on slides
mycosis fungoides/sezary syndrome
affect CD4+
predilection for skin
generalized exfoliative erythema of skin
leukemia with sezary cells
transformation to large cell is a terminal event
classification of HL
Nodular sclerosis
mixed cellularity
lymphocyte rich
lymphocyte depletion
lymphocyte predominance
ANN ARBOR Staging of HL
Stage I=involvement of a single node group or extranodal site
StageII=involvement of 2 or more node groups on the same side of the diaphragm
StageIII=involvement of nodes on both sides of diaphragm and may include spleen
StageIV=multiple foci of involvement of extra lymphatic organs
A=no systemic symptoms
B=systemic symptoms, fever, night sweats, weight loss over 10% body weight
RS cells stain
CD15,30+ but CD45- and other T cell markers
mixed cellularity type of HL
strongly associated with EBV
more systemic effects and advanced stage than nodular sclerosis but good prognosis
lymphocyte depleted type of HL
DDx is large cell lymphoma and therefore phenotyping is important
older pts, HIV+ and EBV associated
less favorable prognosis
lymphocyte rich type of HL
EBV in 40% of cases
CD15,30+ but CD45,20-
good to excellent prognosis
lymphocyte predominant type of HL
popcorn cells
CD20+ and BCL6+
males,young age, cervical or axillary adenopathy
excellent prognosis
RS cells

Differences between HL and NHL
HL=orderly spread, Waldeyer’s ring rare, rarely extra nodal, stage is most important
NHL=non-contiguous, Waldeyer’s ring common, commonly extra nodal, type is most important
Myeloproliferative disease
RBC–>polycythemia vera
WBC–>CML
Megakaryocytes–>essential thrombocytosis (>600,000), primary myelofibrosis
CML etiology
25-60 y/o
translocation involving BCR gene on chromosome 9 and ABL gene on chromosome22 (ph chromosome)
fusion protein tyrosine kinase–>cell division and inhibition of apoptosis